Abstract:OBJECTIVE:To investigate the role of standard treatment with ultrasound-guided radiofrequency ablation (RFA) in improving the treatment level of liver malignancies.METHODS:302 patients with 476 liver malignancies were treated with established protocol and adjuvant measures and subjected to efficiency analysis. In the 302 patients, 181 had 282 hepatocellular carcinomas (HCC) with a mean diameter of 4.2 cm, and 121 had 194 metastatic liver carcinomas (MLC) with a mean diameter of 3.9 cm. According to UICC-TNM system 50 patients (27.6%) were in stage I/II and 131 (72.4%) in stage III/IV (including 39 patients with recurrent HCC after surgical resection). A standard protocol and an individualized protocol were used to treat the tumors based on their size, shape and special location such as the distance from diaphragm, gallbladder and gastrointestinal tract. Needle placement method and operation skill for the tumor region adjacent to important structures were described. Some adjuvant measures such as supplementary fine needle localization, local saline injection and feeding vessel ablation were used to improve RFA efficacy in tumors with different features. Local ablation of bleeding site and haemostatic administration systemically were adopted to deal with bleeding. For the patients with tumor adjacent to gastrointestinal tract, prolonged fasting after the RFA procedure was required. the patients were followed up regularly to assess the treatment efficiency, and the tumor was considered complete necrosed if no viability was found on enhanced CT or enhanced US one month after RFA.RESULTS:The tumor necrosis rate was 95.7% (270/282 tumors) for HCC, 94.8% (184/194 tumors) for MLC, 91.1% (51/56 tumors) for tumor near gastrointestinal tract, 88.5% (69/78 tumors) for tumors near diaphragm, and 94.3% (49/52 tumors) for tumor near gallbladder. The local recurrence rate was 10.3% (29/282 tumors) for HCC and 14.4% (28/194 tumors) for MLC. The 1, 2 and 3 year overall survival rates were 87.6%, 67.4% and 58.6% in the HCC patients, and 87.4%, 48.2%, 25.3% in the MLC patients respectively. The 1, 2 and 3 year survival rates of 50 HCC patients in early (I-II) stages were 90.7%, 85.9% and 73.7%, respectively. The incidence of complications was 2.2% (13/583 sessions), including 5 cases of hemorrhage, 1 case colon perforation, 8 cases of injury of adjacent structures.CONCLUSION:Application of proper protocol and adjuvant measures plays an important role in improving tumor ablation rate. Knowledge about possible complications and their control may increase the treatment efficacy and help to promote the use of RFA technique.

Imaging Evaluation of Efficacy of Radiofrequency Ablation Treatment for Hepatic Cancer

Bipolar Radiofrequency Ablation for Liver Tumors: Comparison of Contrast-Enhanced Ultrasound with Contrast-Enhanced MRI/CT in the Posttreatment Imaging Evaluation.

Imaging Evaluation on the Curative Effect of Radiofrequency Ablation for Primary Hepatic Carcinoma

[Results of Enhanced Ultrasonography in Assessing Hepatoma Treated with Radiofrequency Ablation].

Local therapeutic efficacy of ultrasound-guided percutaneous bipolar radiofrequency ablation for liver cancer

Value of ultrasound-guided radiofrequency ablation treatment for hepatic carcinoma

Fusion Imaging of Contrast-Enhanced Ultrasound and Contrast-Enhanced CT or MRI Before Radiofrequency Ablation for Liver Cancers

Efficacy of Ultrasound-Guided Percutaneous Radiofrequency Ablation of Hepatic Metastases

Ultrasound-guided radiofrequency ablation for the treatment of hepatic metastases:analysis of 136 cases

[Efficacy of Radiofrequency Ablation of 343 Patients with Hepatic Tumor and the Relevant Complications].

Ultrasonic imaging assessment on the ablation therapy of massive hepatic cancer induced by HIFU combined with RFA

Evaluation of Short-Term Efficiency and Affecting Factors of Radiofrequency Ablation Guided by Sonography in Hepatic Malignant Tumors

Percutaneous Radiofrequency Ablation of Malignant Liver Tumors with Ultrasound and CT Fusion Imaging Guidance.

Treatment Efficacy of Radiofrequency Ablation of 338 Patients with Hepatic Malignant Tumor and the Relevant Complications.

[The Importance of Image Guided Radiofrequency Ablation with Standard Treatment Strategy for Liver Malignancies].

Ultrasound-guided Radiofrequency Ablation of Malignant Hepatic Tumors

Clinical application of radiofrequency ablation for hepatic malignant tumors under guidance of contrast-enhanced ultrasound

Imaging Instructed Standardized Treatment for Hepatocellular Carcinoma with Radiofrequency Ablation

Ultrasound-guided radiofrequency ablation for the treatment of 131 patients with malignant hepatic tumors

CT Arterioportography and CT Arteriography in Evaluating Therapeutic Response of Hepatic Malignancies after Radiofrequency Ablation

Comparison of computed tomography versus magnetic resonance imaging in assessing radiofrequency ablation margins after radiofrequency ablation in patients with hepatocellular carcinomas.